Blog
RSS FeedPosted by Michael Wonder on 05 Aug 2020
Moderna is pricing coronavirus vaccine at $32 to $37 per dose for some customers
5 August 2020 - The company defines a small order of its vaccine as “in the millions.” ...
Posted by Michael Wonder on 05 Aug 2020
Johnson & Johnson reaches deal with U.S. for 100 million doses of coronavirus vaccine at more than $1 billion
5 August 2020 - The doses will be provided to Americans at no cost if they’re used in a COVID-19 vaccination ...
Posted by Michael Wonder on 31 Jul 2020
Sanofi and GSK selected for Operation Warp Speed to supply United States government with 100 million doses of COVID-19 vaccine
31 July 2020 - Promising vaccine candidate selected by U.S. government’s Operation Warp Speed. ...
Posted by Michael Wonder on 22 Jul 2020
Pfizer vaccine deal at $20 a dose sets ceiling for rivals
22 July 2020 - U.S. agrees to pay Pfizer, BioNTech $1.95 billion on approval. ...
Posted by Michael Wonder on 12 Jul 2020
Remdesivir: US purchase of world stocks sparks new “hunger games,” warn observers
3 July 2020 - The US has bought up almost all the world’s supply of the antiviral drug remdesivir in ...
Posted by Michael Wonder on 17 Jun 2020
A mad scramble to stock millions of malaria pills, likely for nothing
16 June 2020 - Before the F.D.A. withdrew its waiver to stockpile the drugs as coronavirus treatments, the Trump administration had ...
Posted by Michael Wonder on 17 Jun 2020
An ‘America first’ pharma supply chain sounds good. But it won’t work.
17 June 2020 - With a stroke of the president’s Executive Order pen, the Trump administration awarded a $354 million, ...
Posted by Michael Wonder on 10 Jun 2020
Cardiff Oncology announces expanded access program for onvansertib in KRAS mutated metastatic colorectal cancer as follow-on to fast track designation
9 June 2020 - Expanded Access Program provides pathway for patients to gain access to treatment with onvansertib outside of clinical ...
Posted by Michael Wonder on 09 Jun 2020
The US government's supply of the only proven COVID-19 drug runs out at the end of the month
8 June 2020 - The US government's current supply of remdesivir, the only drug known to work against COVID-19, will ...
Posted by Michael Wonder on 03 Jun 2020
Law makers, government watchdog blast FDA for poor oversight of U.S. drug supply chain
2 June 2020 - A government watchdog blasted the FDA for fumbling its oversight of the safety of the U.S. ...
Posted by Michael Wonder on 03 Jun 2020
Zoloft falls into shortage as virus anxiety strains supplies
2 June 2020 - Drug makers blame increase in demand and ingredient shortfall. ...
Posted by Michael Wonder on 28 May 2020
‘Vaccine nationalism’: a new dynamic in the race to quash coronavirus
27 May 2020 - International pursuit for a shot is shifting into a contest of which world power can immunise its ...
Posted by Michael Wonder on 19 May 2020
CEO tapped by Trump to make generic drugs during pandemic has a dicey track record
19 May 2020 - As the chief executive of Phlow, the new company awarded $354 million by the federal government ...
Posted by Michael Wonder on 19 May 2020
Gilead ups its donation of the COVID-19 drug remdesivir for U.S. hospitals
18 May 2020 - Gilead Sciences, the drug company behind the experimental COVID-19 therapy remdesivir, has upped the number of ...
Posted by Michael Wonder on 19 May 2020
Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV): an unprecedented partnership for unprecedented times
18 May 2020 - It has been more than a century since the world has encountered a pandemic like coronavirus disease ...